• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一般人群中,气流受限、呼吸困难以及两者的发展:长滨研究。

Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study.

机构信息

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan.

Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Sci Rep. 2022 Nov 21;12(1):20060. doi: 10.1038/s41598-022-24657-w.

DOI:10.1038/s41598-022-24657-w
PMID:36414653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9681883/
Abstract

Subjects with subclinical respiratory dysfunction who do not meet the chronic obstructive pulmonary disease (COPD) criteria have attracted attention with regard to early COPD intervention. Our aim was to longitudinally investigate the risks for the development of airflow limitation (AFL) and dyspnoea, the main characteristics of COPD, in a large-scale community-based general population study. The Nagahama study included 9789 inhabitants, and a follow-up evaluation was conducted after 5 years. AFL was diagnosed using a fixed ratio (forced expiratory volume in one second (FEV)/forced vital capacity (FVC) < 0.7). We enrolled normal subjects aged 40-75 years with no AFL, dyspnoea or prior diagnosis of asthma or COPD at baseline. In total, 5865 subjects were analysed, 310 subjects had subclinical respiratory dysfunction (FEV/FVC < the lower limit of normal; n = 57, and FEV < 80% of the predicted value (preserved ratio impaired spirometry); n = 256). A total of 5086 subjects attended the follow-up assessment, and 449 and 1021 subjects developed AFL and dyspnoea, respectively. Of these, 100 subjects developed AFL with dyspnoea. Baseline subclinical respiratory dysfunction was independently and significantly associated with AFL with dyspnoea development within 5 years. Subjects with subclinical respiratory dysfunction are at risk of developing COPD-like features and require careful monitoring.

摘要

对于不符合慢性阻塞性肺疾病 (COPD) 标准的亚临床呼吸功能障碍患者,早期 COPD 干预引起了关注。我们的目的是在一项大规模的基于社区的一般人群研究中,对亚临床呼吸功能障碍患者发展为气流受限 (AFL) 和呼吸困难的风险进行纵向研究,这是 COPD 的主要特征。长滨研究纳入了 9789 名居民,并在 5 年后进行了随访评估。AFL 使用固定比值(一秒用力呼气量 (FEV)/用力肺活量 (FVC) < 0.7)进行诊断。我们招募了在基线时无 AFL、呼吸困难或既往哮喘或 COPD 诊断的年龄在 40-75 岁之间的正常受试者。共有 5865 名受试者进行了分析,310 名受试者有亚临床呼吸功能障碍(FEV/FVC < 正常下限;n=57,和 FEV < 预测值的 80%(保留比受损的肺量测定法);n=256)。共有 5086 名受试者参加了随访评估,449 名和 1021 名受试者分别发展为 AFL 和呼吸困难。其中,100 名受试者出现 AFL 伴呼吸困难。基线亚临床呼吸功能障碍与 5 年内 AFL 伴呼吸困难的发展独立且显著相关。有亚临床呼吸功能障碍的患者有发展为 COPD 样特征的风险,需要密切监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/9681883/136ec30db00c/41598_2022_24657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/9681883/3b39d391c717/41598_2022_24657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/9681883/136ec30db00c/41598_2022_24657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/9681883/3b39d391c717/41598_2022_24657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5028/9681883/136ec30db00c/41598_2022_24657_Fig2_HTML.jpg

相似文献

1
Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study.在一般人群中,气流受限、呼吸困难以及两者的发展:长滨研究。
Sci Rep. 2022 Nov 21;12(1):20060. doi: 10.1038/s41598-022-24657-w.
2
Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.慢性阻塞性肺疾病中FEV1/FVC固定比值与正常下限的临床相关性:来自加拿大慢性阻塞性肺疾病队列研究的患者报告结局
Ann Fam Med. 2015 Jan-Feb;13(1):41-8. doi: 10.1370/afm.1714.
3
How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population.COPD 患者报告结局、健康状况、呼吸困难和呼吸系统症状有何不同?一项工作人群中的观察性研究。
BMJ Open. 2019 Jul 24;9(7):e025132. doi: 10.1136/bmjopen-2018-025132.
4
Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study.超重和肥胖可能导致气流受限诊断不足:哥本哈根城市心脏研究的结果
COPD. 2015 Feb;12(1):5-13. doi: 10.3109/15412555.2014.933955. Epub 2014 Oct 7.
5
Longitudinal Changes and Association of Respiratory Symptoms with Preserved Ratio Impaired Spirometry (PRISm): The Nagahama Study.纵向变化以及呼吸症状与肺量计测定比值正常但存在气流受限(PRISm)的关联:长滨研究
Ann Am Thorac Soc. 2023 Nov;20(11):1578-1586. doi: 10.1513/AnnalsATS.202301-050OC.
6
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.伴有轻度气流受限的慢性阻塞性肺疾病:当前认知与未来研究建议——六家科学学会的共识文件
Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017.
7
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.使用 GLI-2012、GOLD 和澳大利亚 COPD-X 建议评估 COPD 土著人群中肺功能气流受限严重程度的影响:一项澳大利亚土著人视角的研究。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001135.
8
COPD in chronic heart failure: less common than previously thought?慢性心力衰竭合并 COPD:比以前认为的更少见?
Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.
9
Influences of Two FEV Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.两种 FEV 参考方程(GLI-2012 和 GIRH-2017)对 COPD 患者气流受限分类的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022.
10
Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?高危人群中慢性阻塞性肺疾病的检测:诊断检查应包括支气管扩张剂可逆性测试吗?
Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.

引用本文的文献

1
Risk of All-Cause Mortality in US Adults With Preserved Ratio Impaired Spirometry: An Observational Study.美国肺量计比率受损但保留的成年人全因死亡率风险:一项观察性研究。
Int J Chron Obstruct Pulmon Dis. 2025 Feb 11;20:287-302. doi: 10.2147/COPD.S497674. eCollection 2025.
2
Phenotype to Treatable Traits-Based Management in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中基于表型到可治疗特征的管理
Cureus. 2024 May 16;16(5):e60423. doi: 10.7759/cureus.60423. eCollection 2024 May.

本文引用的文献

1
How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?如何在临床实践中利用CAT和mMRC评分评估慢性阻塞性肺疾病患者的症状状态?
Medeni Med J. 2022 Jun 23;37(2):173-179. doi: 10.4274/MMJ.galenos.2022.06787.
2
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
3
A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.
COPDGene®研究中吸烟者死亡率的风险预测模型
Chronic Obstr Pulm Dis. 2020 Oct;7(4):346-361. doi: 10.15326/jcopdf.7.4.2020.0146.
4
Looking at the COPD spectrum through "PRISm".通过“PRISm”审视慢性阻塞性肺疾病谱。
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.02217-2019. Print 2020 Jan.
5
Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.肺活量测定值保存比例受损的轨迹与死亡率:鹿特丹研究
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.01217-2019. Print 2020 Jan.
6
<Editors' Choice> Renewed Japanese spirometric reference variables and risk stratification for postoperative outcomes in COPD patients with resected lung cancer.<编辑推荐> 日本更新的肺量计参考变量及肺癌切除术后慢性阻塞性肺疾病(COPD)患者术后结局的风险分层
Nagoya J Med Sci. 2019 Aug;81(3):427-438. doi: 10.18999/nagjms.81.3.427.
7
Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study.成人肺功能的生命历程轨迹与肺气肿的发生:CARDIA 肺研究。
Am J Med. 2020 Feb;133(2):222-230.e11. doi: 10.1016/j.amjmed.2019.06.049. Epub 2019 Jul 29.
8
Airflow Obstruction and Cardio-metabolic Comorbidities.气流阻塞与心血管代谢合并症。
COPD. 2019 Apr;16(2):109-117. doi: 10.1080/15412555.2019.1614550. Epub 2019 May 27.
9
Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study.日本一般人群中气流受限流行趋势的研究:两次来自兵库县队列研究的连续横断面调查。
BMJ Open. 2019 Mar 20;9(3):e023673. doi: 10.1136/bmjopen-2018-023673.
10
COPD Guidelines: A Review of the 2018 GOLD Report.COPD 指南:2018 GOLD 报告综述。
Mayo Clin Proc. 2018 Oct;93(10):1488-1502. doi: 10.1016/j.mayocp.2018.05.026.